In fact, teriparatide (TPTD), the N-terminal 34 amino acids fragment of PTH, is currently the only bone anabolic agent used for the treatment of osteoporosis, by daily or weekly subcutaneous administration [6, 7]. The gene discussed is PTH; the disease is osteoporosis.